Omecu

Omecu

The next standard in genomics analysis.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

N/A

Grant
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2023
Revenues0000
EBITDA0000
Profit0000
EV0000
EV / revenue00.0x
EV / EBITDA00.0x
R&D budget0000

Source: Dealroom estimates

More about Omecu
Made with AI
Edit

Omecu operates in the genomic data analysis sector, providing a cloud-based platform optimized for real-time, interactive analysis of large genomic and health-related datasets. The platform is designed to enhance user experience by allowing clients to derive actionable insights swiftly, without the delays typically associated with data processing. Omecu's architecture ensures data security, enabling users to maintain control over their data within their own environments. The company primarily serves clients in the healthcare and research industries, focusing on customer satisfaction and efficient data handling. Omecu's business model likely involves subscription-based access to its platform, generating revenue through service fees. The company positions itself as a key player in the fast-evolving field of genomic analysis, addressing the growing demand for rapid and secure data processing solutions.

Keywords: genomic, data analysis, cloud-based, real-time, secure, insights, healthcare, research, platform, customer satisfaction

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads